Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in- Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Beginning balance at Jan. 02, 2021 $ 51 $ 260,260 $ (7,146) $ (215) $ (169,461) $ 83,489
Beginning balance (in shares) at Jan. 02, 2021 48,091          
Increase (Decrease) in Stockholders' Equity            
Net income (loss)         (2,722) (2,722)
Issuance of shares in connection with stock option exercise   163       163
Issuance of shares in connection with stock option exercise (in shares) 130          
Issuance of shares in connection with restricted stock units vesting $ 2 (6)       (4)
Issuance of shares in connection with restricted stock units vesting (in shares) 2,382          
Issuance of shares in connection with BOD Fees   6       6
Share-based compensation   4,080       4,080
Unrealized gain (loss) on deferred compensation trust assets       35   35
Effect of changes in foreign currencies       14   14
Ending balance at Apr. 03, 2021 $ 53 264,503 (7,146) (166) (172,183) 85,061
Ending balance (in shares) at Apr. 03, 2021 50,603          
Beginning balance at Jan. 01, 2022 $ 56 282,663 (7,625) 274 (179,800) 95,568
Beginning balance (in shares) at Jan. 01, 2022 52,960          
Increase (Decrease) in Stockholders' Equity            
Net income (loss)         2,103 2,103
Issuance of shares in connection with stock option exercise   792       $ 792
Issuance of shares in connection with stock option exercise (in shares) 533         533
Issuance of shares in connection with restricted stock units vesting $ 1 (1)        
Issuance of shares in connection with restricted stock units vesting (in shares) 519          
Issuance of stock awards to consultants   81       $ 81
Issuance of stock awards to consultants 10          
Issuance of shares in connection with BOD Fees   6       6
Issuance of shares in connection with ESPP   431       431
Issuance of shares in connection with ESPP 45          
Officers and directors stock purchase plan $ 3 23       23
Share-based compensation   4,225       4,225
Unrealized gain (loss) on deferred compensation trust assets       (34)   (34)
Effect of changes in foreign currencies       20   20
Ending balance at Apr. 02, 2022 $ 57 $ 288,220 $ (7,625) $ 260 $ (177,697) $ 103,215
Ending balance (in shares) at Apr. 02, 2022 54,070